Come and meet us in Arablab 2023 Biowest, the world-respected supplier of animal sera and cell culture media, will attend Arablab, in Dubai. Biowest will exhibit Arablab, with a display that provides a representative overview of its wide range of animal sera and cell culture reagent. Get your free tickets

Actualités Come and meet us in Forum Labo 2023 Biowest, the world-respected supplier of animal sera and cell culture media, will attend Forum Labo Paris, Portes de Versailles. Biowest will exhibit on Booth B12, with a display that provides a representative overview of its wide range of animal sera and cell culture reagent. Get your free tickets

Actualités Biowest, winner of the France Recovery Plan with its MESPRCC project Biowest is very pleased to announce that it has been chosen as the laureate of the #FranceRelance Plan with its “MESPRCC” project (Modernisation and Extension of the Cell Culture Reagent Production Site). As part of the recovery plan, the Ministry for the Economy, Finance and the Recovery has decided to create a fund to support industrial investment in strategic sectors for the resilience of our economy. The call for projects is to support the best investment projects likely to strengthen the autonomy and resilience of French industrial sectors. The aim is to reduce their degree of dependence on non-European…

Actualités Biowest label – redesign As you might know, we recently updated last year our visual identity to reinforce our ambitions and our international dimensions.It is the continuity of that change. From now on, you will start to see our new label in each of our deliveries to you.Discover our wide range of media : Cell culture.

Authors:Armas López Leonel, Piña-Sánchez Patricia, Arrieta Oscar, Guzman de Alba Enrique, Ortiz Quintero Blanca, Santillán Doherty Patricio, Christiani David C., Zúñiga Joaquín and Ávila-Moreno Federico   Abstracts: Several homeobox-related gene (HOX) transcription factors such as mesenchyme HOX-2 (MEOX2) have previously been associated with cancer drug resistance, malignant progression and/or clinical prognostic responses in lung cancer patients; however, the mechanisms involved in these responses have yet to be elucidated. Here, an epigenomic strategy was implemented to identify novel MEOX2 gene promoter transcription targets and propose a new molecular mechanism underlying lung cancer drug resistance and poor clinical prognosis. Chromatin immunoprecipitation (ChIP) assays derived from non-small cell lung carcinomas (NSCLC) hybridized on…

Authors: Tabitha E. Hoornweg, Gert‑Jan Godeke, Marieke N. Hoogerwerf, Puck B. van Kasteren, Ankje de Vries, Hein Sprong, Georges M. G. M. Verjans, Debby van Riel , Johan H. J. Reimerink, Barry Rockx & Chantal B. E. M. Reusken   Abstracts: Tick-borne encephalitis virus (TBEV) may cause tick-borne encephalitis (TBE), a potential lifethreatening infection of the central nervous system in humans. Phylogenetically, TBEVs can be subdivided into three main subtypes, which differ in endemic region and pathogenic potential. In 2016, TBEV was first detected in the Netherlands. One of two detected strains, referred to as Salland, belonged to the TBEV-Eu subtype, yet diverged ≥ 2% on amino acid level from…